Penn Medicine's Melanoma and Pigmented Lesion Program was among the first in the country to provide information, evaluation, and genetic counseling for those at increased risk for melanoma and to create a model for melanoma screening.
A Multidisciplinary Approach to Care
Penn Medicine's multidisciplinary team includes specialists in:
- medical oncology
- surgical oncology
- radiation oncology
- plastic surgery
- head and neck surgery
- psychosocial oncology
Abramson Cancer Center
The Penn Difference
- A nationally recognized team of doctors who have worked together for years caring for patients who have melanoma or are at risk for developing the cancer.
- A first of its kind interdisciplinary Melanoma and Pigmented Lesion Program.
- Expert diagnosticians whose skills are needed to precisely diagnose melanoma.
- Individualized attention and personalized care plans.
- A strong focus on education and monitoring so that melanoma can be prevented or caught early.
- Emphasis on the family, since melanoma risk can be high among family members.
- Innovative treatments and clinical trials unavailable at most hospitals or cancer centers.
- Integration into a comprehensive research program in melanoma that is nationally recognized and funded by the National Cancer Institute, ensuring that the latest discovery is translated to better patient care immediately.
- A National Cancer Institute (NCI)-approved and funded melanoma research program considered by other melanoma scientists to be one of the leading programs in the country, and has been rated "outstanding" by the NCI.
Melanoma Physicians and Team
Penn hematologists/oncologists that treat melanoma at Penn Medicine include:
Today, more and more people are surviving cancer. It is because of clinical trials, many of which are conducted at Penn Medicine, that patients are benefiting from breakthrough therapies and treatments. These new advances in cancer treatment are occurring every day, giving patients hope that even greater discoveries lie ahead.